京新药业(002020.SZ)： 拟推第四期员工持股计划

Group 1 - The core point of the article is that Jingxin Pharmaceutical (002020.SZ) has announced its fourth employee stock ownership plan, aiming to raise a total of no more than RMB 150 million [1] - The employee stock ownership plan will allow employees to participate in the plan with a subscription unit of "shares," with each share priced at RMB 1, totaling up to 150 million shares [1] - The plan involves purchasing the company's repurchased shares at a price of RMB 12.50 per share, including reserved shares, with a total of 12 million shares involved, accounting for approximately 1.39% of the company's existing total share capital of 861.02914 million shares [1] Group 2 - The initial transfer portion of the plan consists of 10.52 million shares, which represents 87.67% of the total shares involved in this employee stock ownership plan [1]